{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:44:18Z","timestamp":1772775858183,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11064-019-02735-2","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T07:09:37Z","timestamp":1548659377000},"page":"1043-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Anticonvulsant Activity of Pterostilbene in Zebrafish and Mouse Acute Seizure Tests"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-7343","authenticated-orcid":false,"given":"Dorota","family":"Nieoczym","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-2080","authenticated-orcid":false,"given":"Katarzyna","family":"Soca\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-847X","authenticated-orcid":false,"given":"Kinga","family":"Gawel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-8094","authenticated-orcid":false,"given":"Camila V.","family":"Esguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-0574","authenticated-orcid":false,"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-0241","authenticated-orcid":false,"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"2735_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Moshe","year":"2015","unstructured":"Moshe SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 385:884\u2013898","journal-title":"Lancet"},{"key":"2735_CR2","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/ph3072090","volume":"3","author":"A Wahab","year":"2010","unstructured":"Wahab A (2010) Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals 3:2090\u20132110","journal-title":"Pharmaceuticals"},{"key":"2735_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3988\/jcn.2014.10.3.175","volume":"10","author":"OY Kwon","year":"2014","unstructured":"Kwon OY, Park SP (2014) Depression and anxiety in people with epilepsy. J Clin Neurol 10:175\u2013188","journal-title":"J Clin Neurol"},{"key":"2735_CR4","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.neurobiolaging.2011.08.015","volume":"33","author":"J Chang","year":"2012","unstructured":"Chang J, Rimando A, Pallas M, Camins A, Porquet D, Reeves J, Shukitt-Hale B, Smith MA, Joseph JA, Casadesus G (2012) Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer\u2019s disease. Neurobiol Aging 33:2062\u20132071","journal-title":"Neurobiol Aging"},{"key":"2735_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2016.07.046","volume":"789","author":"R Kosuru","year":"2016","unstructured":"Kosuru R, Rai U, Prakash S, Singh A, Singh S (2016) Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence. Eur J Pharmacol 789:229\u2013243","journal-title":"Eur J Pharmacol"},{"key":"2735_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuint.2015.07.017","volume":"89","author":"SM Poulose","year":"2015","unstructured":"Poulose SM, Thangthaeng N, Miller MG, Shukitt-Hale B (2015) Effects of pterostilbene and resveratrol on brain and behavior. Neurochem Int 89:227\u2013233","journal-title":"Neurochem Int"},{"key":"2735_CR7","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/mnfr.201400244","volume":"58","author":"M Azzolini","year":"2014","unstructured":"Azzolini M, La SM, Mattarei A, Paradisi C, Zoratti M, Biasutto L (2014) Pharmacokinetics and tissue distribution of pterostilbene in the rat. Mol Nutr Food Res 58:2122\u20132132","journal-title":"Mol Nutr Food Res"},{"key":"2735_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/s-0032-1328553","volume":"79","author":"M Al Rahim","year":"2013","unstructured":"Al Rahim M, Rimando AM, Silistreli K, El-Alfy AT (2013) Anxiolytic action of pterostilbene: involvement of hippocampal ERK phosphorylation. Planta Med 79:723\u2013730","journal-title":"Planta Med"},{"key":"2735_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","volume":"131","author":"SC Baraban","year":"2005","unstructured":"Baraban SC, Taylor MR, Castro PA, Baier H (2005) Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131:759\u2013768","journal-title":"Neuroscience"},{"key":"2735_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/cn400140e","volume":"4","author":"OE Buenafe","year":"2013","unstructured":"Buenafe OE, Orellana-Paucar A, Maes J, Huang H, Ying X, De BW, Crawford AD, Luyten W, Esguerra CV de WP (2013) Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models. ACS Chem Neurosci 4:1479\u20131487","journal-title":"ACS Chem Neurosci"},{"key":"2735_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yebeh.2012.02.020","volume":"24","author":"AM Orellana-Paucar","year":"2012","unstructured":"Orellana-Paucar AM, Serruys AS, Afrikanova T, Maes J, De BW, Alen J, Leon-Tamariz F, Wilches-Arizabala IM, Crawford AD, de Witte PA, Esguerra CV (2012) Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models. Epilepsy Behav 24:14\u201322","journal-title":"Epilepsy Behav"},{"key":"2735_CR12","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2735_CR13","doi-asserted-by":"publisher","first-page":"e54166","DOI":"10.1371\/journal.pone.0054166","volume":"8","author":"T Afrikanova","year":"2013","unstructured":"Afrikanova T, Serruys AS, Buenafe OE, Clinckers R, Smolders I, de Witte PA, Crawford AD, Esguerra CV (2013) Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs. PLoS ONE 8:e54166","journal-title":"PLoS ONE"},{"key":"2735_CR14","doi-asserted-by":"publisher","first-page":"e0125898","DOI":"10.1371\/journal.pone.0125898","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Kecskes A, Copmans D, Langlois M, Crawford AD, Ceulemans B, Lagae L, de Witte PA, Esguerra CV (2015) Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine. PLoS ONE 10:e0125898","journal-title":"PLoS ONE"},{"key":"2735_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3570549","volume":"7","author":"AW Kimball","year":"1957","unstructured":"Kimball AW, Burnett WT Jr, Doherty DG (1957) Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 7:1\u201312","journal-title":"Radiat Res"},{"key":"2735_CR16","first-page":"99","volume":"96","author":"JT Litchfield Jr","year":"1949","unstructured":"Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"2735_CR17","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233\u2013236","journal-title":"Neurobehav Toxicol"},{"key":"2735_CR18","first-page":"81","volume":"3","author":"JR Boissier","year":"1960","unstructured":"Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l\u2019action \u201ctranquillisante\u201d:le test de la cheminee. Med Exp 3:81\u201384","journal-title":"Med Exp"},{"key":"2735_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2741\/4267","volume":"19","author":"M Pallas","year":"2014","unstructured":"Pallas M, Ortuno-Sahagun D, Andres-Benito P, Ponce-Regalado MD, Rojas-Mayorquin AE (2014) Resveratrol in epilepsy: preventive or treatment opportunities? Front Biosci 19:1057\u20131064","journal-title":"Front Biosci"},{"key":"2735_CR20","doi-asserted-by":"publisher","unstructured":"Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6 https:\/\/doi.org\/10.3390\/biomedicines6030091","DOI":"10.3390\/biomedicines6030091"},{"key":"2735_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00281","author":"N Aourz","year":"2018","unstructured":"Aourz N, Serruys AK, Chabwine JN, Balegamire PB, Afrikanova T, Edrada-Ebel R, Grey AI, Kamuhabwa AR, Walrave L, Esguerra CV, van LF, de Witte, Smolders PAM, Crawford I AD (2018) Identification of GSK-3 as a potential therapeutic entry point for epilepsy. ACS Chem Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.8b00281","journal-title":"ACS Chem Neurosci"},{"key":"2735_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eplepsyres.2016.05.016","volume":"126","author":"W L\u00f6scher","year":"2016","unstructured":"L\u00f6scher W (2016) Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies. Epilepsy Res 126:157\u2013184","journal-title":"Epilepsy Res"},{"key":"2735_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1358\/mf.2009.31.2.1338414","volume":"31","author":"MM Castel-Branco","year":"2009","unstructured":"Castel-Branco MM, Alves GL, Figueiredo IV, Falcao AC, Caramona MM (2009) The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Methods Find Exp Clin Pharmacol 31:101\u2013106","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2735_CR24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","volume":"16","author":"SN Mandhane","year":"2007","unstructured":"Mandhane SN, Aavula K, Rajamannar T (2007) Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure 16:636\u2013644","journal-title":"Seizure"},{"key":"2735_CR25","volume-title":"Neuropharmacology methods in epilepsy research","author":"HS White","year":"1998","unstructured":"White HS (1998) Chemoconvulsants. Pages 27\u201340. In: Peterson SL, Albertson TE (eds) Neuropharmacology methods in epilepsy research. CRC Press, Boca Raton"},{"key":"2735_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","volume":"47","author":"ME Barton","year":"2001","unstructured":"Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217\u2013227","journal-title":"Epilepsy Res"},{"key":"2735_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.bmc.2014.01.008","volume":"22","author":"DC Rueda","year":"2014","unstructured":"Rueda DC, Schoffmann A, De MM, Raith M, Jahne EA, Hering S, Hamburger M (2014) Identification of dihydrostilbenes in Pholidota chinensis as a new scaffold for GABAA receptor modulators. Bioorg Med Chem 22:1276\u20131284","journal-title":"Bioorg Med Chem"},{"key":"2735_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000058044","volume":"65","author":"YK Gupta","year":"2002","unstructured":"Gupta YK, Chaudhary G, Srivastava AK (2002) Protective effect of resveratrol against pentylenetetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology 65:170\u2013174","journal-title":"Pharmacology"},{"key":"2735_CR29","first-page":"133","volume":"4","author":"NI Amany","year":"2014","unstructured":"Amany NI, Anjuman GM (2014) Anticonvulsant effect of resveratrol against pentylenetetrazole induced-epilepsy in rats: role of nitric oxide. Int J Clin Pharmacol Res 4:133\u2013138","journal-title":"Int J Clin Pharmacol Res"},{"key":"2735_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neulet.2016.09.002","volume":"632","author":"F Tomaciello","year":"2016","unstructured":"Tomaciello F, Leclercq K, Kami\u0144ski RM (2016) Resveratrol lacks protective activity against acute seizures in mouse models. Neurosci Lett 632:199\u2013203","journal-title":"Neurosci Lett"},{"key":"2735_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pharmthera.2011.04.008","volume":"131","author":"AK Shetty","year":"2011","unstructured":"Shetty AK (2011) Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol Ther 131:269\u2013286","journal-title":"Pharmacol Ther"},{"key":"2735_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.brainres.2012.11.027","volume":"1492","author":"SJ Wang","year":"2013","unstructured":"Wang SJ, Bo QY, Zhao XH, Yang X, Chi ZF, Liu XW (2013) Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Res 1492:122\u2013129","journal-title":"Brain Res"},{"key":"2735_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.47","volume":"29","author":"F Alyu","year":"2017","unstructured":"Alyu F, Dikmen M (2017) Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr 29:1\u201316","journal-title":"Acta Neuropsychiatr"},{"key":"2735_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tips.2016.03.001","volume":"37","author":"A Dey","year":"2016","unstructured":"Dey A, Kang X, Qiu J, Du Y, Jiang J (2016) Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci 37:463\u2013484","journal-title":"Trends Pharmacol Sci"},{"key":"2735_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2018.08.020","volume":"837","author":"YN Paudel","year":"2018","unstructured":"Paudel YN, Shaikh MF, Shah S, Kumari Y, Othman I (2018) Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy. Eur J Pharmacol 837:145\u2013155","journal-title":"Eur J Pharmacol"},{"key":"2735_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijdevneu.2016.08.005","volume":"54","author":"D Li","year":"2016","unstructured":"Li D, Song T, Yang L, Wang X, Yang C, Jiang Y (2016) Neuroprotective actions of pterostilbene on hypoxic-ischemic brain damage in neonatal rats through upregulation of heme oxygenase-1. Int J Dev Neurosci 54:22\u201331","journal-title":"Int J Dev Neurosci"},{"key":"2735_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11571-016-9413-1","volume":"11","author":"B Naik","year":"2017","unstructured":"Naik B, Nirwane A, Majumdar A (2017) Pterostilbene ameliorates intracerebroventricular streptozotocin induced memory decline in rats. Cogn Neurodyn 11:35\u201349","journal-title":"Cogn Neurodyn"},{"key":"2735_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2016.09.027","volume":"1652","author":"X Yin","year":"2016","unstructured":"Yin X, Guven N, Dietis N (2016) Stress-based animal models of depression: Do we actually know what we are doing? Brain Res 1652:30\u201342","journal-title":"Brain Res"},{"key":"2735_CR39","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1007\/s12035-017-0680-6","volume":"55","author":"MR Oliveira de","year":"2018","unstructured":"de Oliveira MR, Chenet AL, Duarte AR, Scaini G, Quevedo J (2018) Molecular mechanisms underlying the anti-depressant effects of resveratrol: a review. Mol Neurobiol 55:4543\u20134559","journal-title":"Mol Neurobiol"},{"key":"2735_CR40","doi-asserted-by":"publisher","unstructured":"Moore A, Beidler J, Hong MY (2018) Resveratrol and depression in animal aodels: a systematic review of the biological mechanisms. Molecules 23 https:\/\/doi.org\/10.3390\/molecules23092197","DOI":"10.3390\/molecules23092197"},{"key":"2735_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2014.03.052","volume":"268","author":"LL Hurley","year":"2014","unstructured":"Hurley LL, Akinfiresoye L, Kalejaiye O, Tizabi Y (2014) Antidepressant effects of resveratrol in an animal model of depression. Behav Brain Res 268:1\u20137","journal-title":"Behav Brain Res"},{"key":"2735_CR42","doi-asserted-by":"crossref","first-page":"56045","DOI":"10.18632\/oncotarget.11178","volume":"7","author":"L Liu","year":"2016","unstructured":"Liu L, Zhang Q, Cai Y, Sun D, He X, Wang L, Yu D, Li X, Xiong X, Xu H, Yang Q, Fan X (2016) Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. Oncotarget 7:56045\u201356059","journal-title":"Oncotarget"},{"issue":"10","key":"2735_CR43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/molecules21101341","volume":"21","author":"YC Li","year":"2016","unstructured":"Li YC, Liu YM, Shen JD, Chen JJ, Pei YY, Fang XY (2016) Resveratrol ameliorates the depressive-like behaviors and metabolic abnormalities induced by chronic corticosterone injection. Molecules 21(10):1341","journal-title":"Molecules"},{"key":"2735_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.brainres.2018.09.027","volume":"1701","author":"AAA El-Fattah","year":"2018","unstructured":"El-Fattah AAA, Fahim AT, Sadik NAH, Mohamed AB (2018) Resveratrol and dimethyl fumarate ameliorate depression-like behaviour in a rat model of chronic unpredictable mild stress. Brain Res 1701:227\u2013236","journal-title":"Brain Res"},{"key":"2735_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5087-1","author":"J Shen","year":"2018","unstructured":"Shen J, Qu C, Xu L, Sun H, Zhang J (2018) Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT\/GSK3beta signaling pathway in hippocampus. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-018-5087-1","journal-title":"Psychopharmacology"},{"key":"2735_CR46","first-page":"499","volume":"72","author":"YY Xu","year":"2017","unstructured":"Xu YY, Liang J, Xia QR (2017) Novel insights into the pharmacological effects of resveratrol on the management of depression: a short review. Pharmazie 72:499\u2013502","journal-title":"Pharmazie"},{"key":"2735_CR47","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG (2012) Adverse effects of antiepileptic drugs. Lancet Neurol 11:792\u2013802","journal-title":"Lancet Neurol"},{"key":"2735_CR48","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1021\/jf803579e","volume":"57","author":"MJ Ruiz","year":"2009","unstructured":"Ruiz MJ, Fernandez M, Pico Y, Manes J, Asensi M, Carda C, Asensio G, Estrela JM (2009) Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57:3180\u20133186","journal-title":"J Agric Food Chem"},{"key":"2735_CR49","doi-asserted-by":"publisher","first-page":"463595","DOI":"10.1155\/2013\/463595","volume":"2013","author":"DM Riche","year":"2013","unstructured":"Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M (2013) Analysis of safety from a human clinical trial with pterostilbene. J Toxicol 2013:463595","journal-title":"J Toxicol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02735-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02735-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02735-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T16:28:23Z","timestamp":1606235303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02735-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02735-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}